LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

Strona główna・Stock List・Geron Corp

Geron Corp

Closed

SectorHealthcare

1.07 -1.83

Buy Sell

Overview

Share price change

24h

Current

Min

1.05

Max

1.1

Key metrics
By Trading Economics
Income	3.5M -16M
Sales	9.4M 49M
Profit margin	-33.394
Employees	229
EBITDA	9.2M -7.6M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+202.75% upside

Market Stats
By TradingEconomics
Market Cap	-5.1M 766M
Previous open	2.9
Previous close	1.07

News Sentiment

By Acuity

27%

73%

73 / 374 Ranking in Healthcare

Geron Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 lis 2025, 23:38 UTC

Earnings

OCBC Posts Steady Third-Quarter Net Profit, Drop in Net Interest Income

6 lis 2025, 23:00 UTC

Earnings

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts -- Update

6 lis 2025, 22:19 UTC

Earnings

Major Market Movers

Block Shares Slide After 3Q Results Miss Estimates

6 lis 2025, 21:53 UTC

Earnings

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q Sales $476M >WPM

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q Adj EPS 61.8c >WPM

6 lis 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 lis 2025, 23:45 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stocks Drop

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q EPS 80.7c >WPM

6 lis 2025, 23:38 UTC

Market Talk

Gold Edges Higher Amid Worrisome Signs for U.S. Economy -- Market Talk

6 lis 2025, 23:15 UTC

Earnings

Kakao 3Q Net Profit Beat FactSet-Compiled Consensus

6 lis 2025, 23:14 UTC

Earnings

Kakao 3Q Net KRW192.86B Vs. Net KRW78.51B >035720.SE

6 lis 2025, 23:14 UTC

Earnings

Kakao 3Q Oper Pft KRW208.05B Vs. Pft KRW130.53B >035720.SE

6 lis 2025, 23:13 UTC

Earnings

Kakao 3Q Rev KRW2.087T Vs. KRW1.921T >035720.SE

6 lis 2025, 23:08 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Total Income S$3.80B Vs. S$3.80B >O39.SG

6 lis 2025, 23:08 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Noninterest Income S$1.57B Vs. S$1.37B >O39.SG

6 lis 2025, 23:07 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Net S$1.98B Vs. Net S$1.97B >O39.SG

6 lis 2025, 23:07 UTC

Earnings

Suzano 3Q Rev BRL12.2B >SUZ

6 lis 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Wheaton Precious Metals to Pay Waterton Gold $670M Up Front

6 lis 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Wheaton Precious Metals to Buy Gold Stream on Spring Valley Project Located in Nevada >WPM

6 lis 2025, 22:45 UTC

Acquisitions, Mergers, Takeovers

Union Pacific and Norfolk Southern Provide Supplemental Disclosures to Joint Proxy Statement About Merger

6 lis 2025, 22:25 UTC

Acquisitions, Mergers, Takeovers

At Bank of America's Investor Day, M&A Hints, Would-Be CEOs, and AI Pitches -- Barrons.com

6 lis 2025, 22:13 UTC

Earnings

Fairfax Financial 3Q Rev $8.27B >FFH.T

6 lis 2025, 22:02 UTC

Earnings

Century Aluminum 3Q Sales $632.2M >CENX

6 lis 2025, 22:02 UTC

Earnings

Century Aluminum 3Q Adj EPS 56c >CENX

6 lis 2025, 21:53 UTC

Earnings

DraftKings Stock Sinks on Disappointing Results -- Barrons.com

6 lis 2025, 21:52 UTC

Acquisitions, Mergers, Takeovers

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

6 lis 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

6 lis 2025, 21:50 UTC

Market Talk

Earnings

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

6 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Geron Corp Forecast

Price Target

By TipRanks

202.75% upside

12 Months Forecast

Average 3.3 USD 202.75%

High 4 USD

Low 1.5 USD

Based on 6 Wall Street analysts offering 12 month price targets forGeron Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Geron Corp - Dist in the past 3 months.

Sentiment

By Acuity

73 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.